Avila Therapeutics Receives $30,000,000 Series B Financing

  • Feed Type
  • Date
    7/27/2009
  • Company Name
    Avila Therapeutics
  • Mailing Address
    100 Beaver Street Waltham, MA 02453
  • Company Description
    Avila Therapeutics, Inc., is a venture-backed company focused on the discovery and development of novel small molecule therapeutics to address significant unmet clinical needs with an initial focus on cancer and viral diseases.
  • Website
    http://www.avilatx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $30,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The new financing will be used to move Avila’s first program into clinical trials, while also advancing the Avilomics drug discovery approach, the company said.
  • M&A Terms
  • Venture Investor
    Novartis Venture Fund
  • Venture Investor
    Abingworth Management Inc
  • Venture Investor
    Advent Venture Partners
  • Venture Investor
    Atlas Venture
  • Venture Investor
    Polaris Venture Partners

Trending on Xconomy